SeaStar Medical Holding Corp

ICU

Company Profile

  • Business description

    SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

  • Contact

    3513 Brighton Boulevard
    Suite 410
    DenverCO80216
    USA

    T: +1 844 427-8100

    https://www.seastarmedical.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    18

Stocks News & Analysis

stocks

Small caps are catching fire

For good reason.
stocks

Moated ASX player’s future growth prospects look solid

We expect the strong earnings momentum at this company to continue, with shares looking fairly valued.
stocks

Ask the analyst: Can this genius product create the next ASX software king?

SiteMinder’s newly released product for hotel owners and travel agents could widen its moat and see revenue accelerate further.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,049.8021.00-0.23%
CAC 407,786.9831.24-0.40%
DAX 4023,359.1829.940.13%
Dow JONES (US)46,018.32260.420.57%
FTSE 1009,208.3712.710.14%
HKSE26,761.93146.46-0.54%
NASDAQ22,261.3372.63-0.33%
Nikkei 22545,419.63629.251.40%
NZX 50 Index13,120.03108.35-0.82%
S&P 5006,600.356.41-0.10%
S&P/ASX 2008,765.4027.50-0.31%
SSE Composite Index3,883.937.590.20%

Market Movers